Delivery Order SPE2DX22D0010-SPE2D825FJB78
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $3,991.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on July 30, 2025, with an ultimate completion date of July 31, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at the...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $3,697.92 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on August 23, 2025, with an ultimate completion date of August 25, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract is performed at the vendor's corporate...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $58,494.96 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on August 18, 2025, with an ultimate completion date of August 19, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The work will be performed...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $3,965.49 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on July 28, 2025, with an ultimate completion date of July 29, 2025. This contract represents a child delivery order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery order utilizes firm fixed price contracting with no...
- The Defense Logistics Agency's Medical Supply Chain awarded a $2,032.71 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on August 11, 2025, with an ultimate completion date of August 12, 2025. This non-set-aside contract represents a child delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.999 billion through December 2026. The delivery order will be performed at...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $9,532.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on July 28, 2025, with completion scheduled for July 29, 2025. This non-set-aside contract represents a child delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work will be performed at the...
- The U.S. Defense Department's Medical Supply Chain awarded a $16,150.49 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on July 24, 2025, with an ultimate completion date of July 25, 2025. This competitively awarded, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December...
- The U.S. Defense Logistics Agency, through its Medical Supply Chain division, awarded a delivery order valued at $11,267.90 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on August 14, 2025. This firm fixed price delivery order, which carries an ultimate completion date of August 15, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award...
- The U.S. Defense Logistics Agency's Medical Supply Chain issued a delivery order valued at $22,572.96 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on August 21, 2025, with an ultimate completion date of August 22, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The order will be...
- The U.S. Defense Logistics Agency's Medical Supply Chain issued a $13,626.54 delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitive, non-set-aside contract was awarded on a firm fixed-price basis and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle. The place of performance is the company's corporate office in Conshohocken, Pennsylvania. This...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D825FJB78Delivery Order
The U.S. Defense Logistics Agency Medical Supply Chain awarded a $7,511.44 firm fixed price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on September 3, 2025, with an ultimate completion date of September 4, 2025. This contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award was competitively procured with no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, leverages its prime IDV to supply pharmaceutical products and medical supplies supporting military and federal healthcare systems globally. The company's extensive federal contract portfolio encompasses brand-name and generic medications, vaccines, specialty drugs, and medical devices across multiple therapeutic domains. This delivery order continues the company's critical role in supporting Defense Health Agency procurement needs and represents one of numerous competitively awarded transactions through AmerisourceBergen's comprehensive pharmaceutical supply vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.5k | 9/3/25 |